alexa Muzafar Ahmad Macha | University Nebraska Medical Cente
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Muzafar Ahmad Macha

Muzafar Ahmad Macha Muzafar Ahmad Macha Department of Biochemistry and Molecular Biology University Nebraska Medical Center USA
Biography

Dr. Macha did his Masters in Biochemistry from Jamia Hamdard, New Delhi, India. He qualified several National level competition exams and was awarded the Junior Research Fellowship (NET-JRF). In year 2005, he joined his doctoral program on Head and Neck Cancers (HNCs) in the Department of Biochemistry at All India Institute of Medical Sciences (AIIMS), New Delhi, India, which is a premier institute of biomedical research in India. During his five years of doctoral training, he worked on the (a) identification of early diagnostic/ prognostic markers (b) anti-cancer activities of natural products on smokeless Tobacco (ST)/nicotine induced oral cancer models (c) identification and characterization of biomarkers as surrogate end points in clinical trials using natural products for advanced HNCs. His doctoral work besides identifying early diagnostic/prognostic markers, facilitated the identification of several molecular targets of ST and nicotine using the in vitro models and provided the molecular basis for the use of GS for chemoprevention of oral carcinogenesis. 

After joining Dr. Batra’s lab as a post-doctoral fellow in 2011 at University of Nebraska Medical Center, USA, he is extensively involved in identifying the novel mechanisms and signaling alterations associated with mucins in HNC pathogenesis using in vitro and in vivo models. His studies have revealed that mucin MUC4 is differentially upregulated in HNCs and prevents cells from undergoing cell Senescence (cell cycle arrest) thereby increases cell proliferation and survival of HNC cells. Over all, with 10 years of research experience in HNCs, he is sure that his studies will help to unravel novel insights into the involvement of mucins in HNC pathogenesis, identify novel diagnostic/ prognosticators and therapeutic targets to combat this deadly disease. 

 

Research Interest

Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models

Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords